You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLA compatible donor

Showing 1 - 25 of 4,537
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

Recruiting
  • Acute Myeloid Leukemia
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022

Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,

Completed
Has Results
  • Acute Myeloid Leukemia
  • Advanced Myelodysplastic Syndromes
  • Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 27, 2021

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

Withdrawn
  • Hematologic Diseases
  • +5 more
  • CliniMACS
  • +7 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Sep 26, 2022

Tissue Specimens From Solid Tumors or Blood Disorders and Their

Recruiting
  • Neoplasms
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +14 more
    • Aldesleukin
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Maternal KIR and Fetal HLA Influence Reproductive Success in

    Recruiting
    • Reproductive Issues
    • Analysis combinations of maternal KIR and HLA-C genotypes
    • Madrid, Spain
      Instituto Valenciano de Infertilidad
    Nov 30, 2022

    Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

    Not yet recruiting
    • Severe Aplastic Anemia
    • (no location specified)
    Oct 1, 2023

    Selection of Allogeneic Hematopoietic Cell Donors Based on KIR

    Active, not recruiting
    • Leukemia
    • KIR genotyping
    • HLA genotyping
    • Tampa, Florida
    • +9 more
    Nov 29, 2022

    GVHD Trial in Nantes (drug, radiation, other)

    Terminated
    • Graft Versus Host Disease
    • Nantes, France
      Nantes Uh
    Jul 13, 2022

    MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Miami, Florida
      Miami Cancer Institute
    Jan 10, 2023

    GVHD Trial (Grafalon, Thymoglobulin)

    Not yet recruiting
    • GVHD
    • (no location specified)
    Oct 9, 2023

    Anemia, Aplastic Trial in United States (Fludarabine, Cyclophosphamide 150mg, Cyclophosphamide 100mg)

    Completed
    Has Results
    • Anemia, Aplastic
    • Phoenix, Arizona
    • +21 more
    Oct 13, 2021

    MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

    Recruiting
    • Myelodysplastic Syndromes
    • Secondary Acute Myeloid Leukemia
    • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
    • Standard of Care Chemotherapy
    • Tampa, Florida
      Moffitt Cancer Center
    Sep 27, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +10 more
    • Jacksonville, Florida
    • +5 more
    Aug 14, 2023

    Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • Leukemia, Lymphocytic, Acute
    • Total Body Irradiation (TBI)
    • +5 more
    • Miami, Florida
      Baptist Health South Florida/Miami Cancer Institute
    Nov 28, 2022

    Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

    Not yet recruiting
    • Acute Leukemia
    • +4 more
    • (no location specified)
    Oct 18, 2022

    Expanding Scope of Post-transplant HLA-specific Antibody

    Not yet recruiting
    • Kidney Transplant
    • +7 more
    • cf-DNA
    • +2 more
    • Liverpool, Merseyside, United Kingdom
      Liverpool University Hospitals NHS Foundation Trust
    Aug 29, 2023

    Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

    Recruiting
    • Myeloid Malignancies
    • Lymphoid Malignancies
    • NK Cell enriched-DLI only
    • NK-DLI + DUK-CPG-001
    • Durham, North Carolina
      Duke University Health System
    Mar 8, 2022

    Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

    Not yet recruiting
    • Acute Leukemia
    • +4 more
    • Haploidentical hematopoietic cell transplantation (haploHCT)
    • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
    • (no location specified)
    Jul 13, 2022

    Kidney Transplant Rejection Trial (MDR-103)

    Not yet recruiting
    • Kidney Transplant Rejection
    • MDR-103
    • (no location specified)
    Apr 4, 2022

    Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute

    Recruiting
    • Acute Rejection of Renal Transplant
    • Graft Failure
    • Donor-derived cell-free DNA
    • Loma Linda, California
      Loma Linda University Health
    Jul 19, 2022

    ddcfDNA in Kidney Transplant Recipients

    Recruiting
    • Kidney Transplant Rejection
    • AlloSeq cfDNA
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Aug 22, 2023

    Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)

    Not yet recruiting
    • Kidney Transplant Rejection
    • MDR-102
    • Immunosuppressive Agents
    • (no location specified)
    Apr 4, 2022

    Intravenous Busulfan And Fludarabine Myeloablative Conditioning

    Completed
    • Acute Myeloid Leukemia
    • +3 more
      • (no location specified)
      Mar 16, 2022